共 7 条
Transfusions of least-incompatible blood with intravenous immunoglobulin plus steroids cover in two patients with rare antibody
被引:15
|作者:
Win, Nay
[1
]
Needs, Malcolm
[1
]
Thornton, Nicole
[2
]
Webster, Robert
[3
]
Chang, Cherry
[4
]
机构:
[1] Natl Blood Serv Tooting Ctr, Dept Red Cell Immunohaematol, Sheffield, S Yorkshire, England
[2] Int Blood Grp Reference Lab, Bristol, Avon, England
[3] NHS Blood & Transplant Sheffield Ctr, Dept Red Cell Immunohaematol, Sheffield, S Yorkshire, England
[4] City Hosp Nottingham, Dept Haematol, Nottingham, England
来源:
关键词:
HEMOLYTIC-DISEASE;
ANTENATAL TREATMENT;
FETUS;
HYPERHEMOLYSIS;
GUIDELINES;
MANAGEMENT;
NEWBORN;
D O I:
10.1111/trf.14648
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
BACKGROUNDThe therapeutic value of the use of intravenous immunoglobulin (IVIG) to correct anemia and thrombocytopenia as a result of immunologic causes (hemolytic disease of the fetus and newborn and fetal or neonatal alloimmune thrombocytopenia) have been well established. Few published papers exist regarding the use of IVIG in adult settings. We report two patients with clinically significant antibodies against high-incidence antigens, who were successfully transfused with incompatible red blood cells (RBCs), in conjunction with IVIG plus steroids and IVIG. CASE REPORTSCase 1 was a 25-year-old patient (Hb SC) who was admitted with low hemoglobin (Hb) and low reticulocyte count. A diagnosis of parvovirus-induced RBC hypoplasia was made. The patient's sample contained anti-E, anti-N, and anti-U. The Hb decreased to 37 g/dL and urgent transfusion was provided with E-, N-, least-incompatible RBC units covered by IVIG and hydrocortisone. Case 2 was a 54-year-old patient who was admitted after a road traffic accident. Nonspecific weak antibody was detected. She received 6 units of least-incompatible RBCs. She was transferred to another hospital and received 2 least-incompatible units. Hb level decreased further and an additional unit was transfused. Samples were referred to the reference laboratory and strong anti-Jr(a) detected. As there was clinical and laboratory evidence of hemolysis and Jr(a-) units were not available, IVIG was prescribed and least-incompatible units were transfused. RESULTSThere were no hemolytic transfusion reactions, hemolysis ceased, and anemia improved in both cases. CONCLUSIONProphylaxis with IVIG plus steroids and IVIG should be considered as a therapeutic option when transfusion of incompatible units is necessary.
引用
收藏
页码:1626 / 1630
页数:5
相关论文